首页 | 本学科首页   官方微博 | 高级检索  
检索        

组合链霉素和利福平抗性突变去甲基万古霉素高产菌株的选育
引用本文:王耀耀,刘云清,朱研研,刘崧,蔡超靖,徐平.组合链霉素和利福平抗性突变去甲基万古霉素高产菌株的选育[J].中国抗生素杂志,2006,31(4):243-246.
作者姓名:王耀耀  刘云清  朱研研  刘崧  蔡超靖  徐平
作者单位:华北制药集团新药研发公司,石家庄,050015
摘    要:在去甲基万古霉寨生产菌株东方拟无枝酸菌的菌种选育中。利用核糖体工程育种方法,筛选得到的新菌株在发酵水平以及改善气丝及孢子生长贫瘠方面均有较大提高。首轮采用链霉素抗性筛选,得到突变株3.30,斜面外观丰满程度明显好于原对照株,发酵效价提高11.9%;第二轮组合链霉素和利福平抗性结合高能电子诱变育种,进一步巩固了育种成效,得到一系列代谢特点呈多样性的菌株,其中04-102发酵水平较原出发菌株提高45.8%,代谢速度加快,传代稳定性亦得到显著改善。

关 键 词:去甲基万古霉素  东方拟无枝酸菌  组合抗性育种
文章编号:1001-8689(2006)04-0243-04
收稿时间:2005-06-07
修稿时间:2005-09-21

Screening of high yield norvancomycin producing strain by streptomycin and rifampicin resistant mutation
Wang Yao-yao,Liu Yun-qing,Zhu Yan-yan,Liu Song,Cai Chao-jing,Xu Ping.Screening of high yield norvancomycin producing strain by streptomycin and rifampicin resistant mutation[J].Chinese Journal of Antibiotics,2006,31(4):243-246.
Authors:Wang Yao-yao  Liu Yun-qing  Zhu Yan-yan  Liu Song  Cai Chao-jing  Xu Ping
Institution:New Drug Research and Development Co., Ltd.,North China Pharmaeentieal Corp , Shijiazhuang 050015
Abstract:To improve the production of norvancomycin, ribosome engineering breeding was adopted to treat Amycolatopsis orentalis with hard electron beam. The mutant 3-30 was obtained by streptomycin-resistance screeni its aerial hyphal and spores output were more abundant than the parent strain, and the potency was increased 11.9%. Furthermore, the combined antibiotics-resistant mutation with obtain mutant 04-102. The potency of mutant 04-102 was increased by of generations were improved. rifampicin and streptomycin was carried out to 45.8% than the parent strain and the stability
Keywords:Norvancomycin  Amycolatopsis orientalis  Combined drug-resistant breeding
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号